OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab by B. Varco-Merth, M. Chaunzwa, D. Duell, A. Marenco, S. Docken, J. Smedley, M.K. Axthelm, S.G. Hansen, M.P. Davenport, J.D. Estes, B. Keele, J.D. Lifson, S.R. Lewin, A.A. Okoye, L.J. Picker

Get full text

SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion by A.A. Okoye, S.R. Lewin, C.H. Xu, M. Vaidya, D.M. Duell, W.B. Brantley, M.A. Marenco, Y. Fukazawa, H.M. Park, T.A. Rasmussen, J.D. Lifson, M.K. Axthelm, S.G. Deeks, L.J. Picker

Get full text

The human IL-15 superagonist complex ALT-803 drives SIV-specific CD8+ T cells into B cell follicles by G. Webb, S. Li, G. Mwakalundwa, J.S. Reed, J.J. Stanton, A.W. Legasse, J. Folkvord, B.S. Park, M.K. Axthelm, E.K. Jeng, H.C. Wong, J.B. Whitney, R. Brad Jones, D.F. Nixon, E. Connick, P.J. Skinner, J.B. Sacha

Get full text